A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis. Bae K, Kim JH, Jung H, Kong SY, et al. Br J Cancer 2021;124:290-298.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bae K, Kim JH, Jung H, Kong SY, et al. A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis. Br J Cancer 2021;124:290-298.
PMID: 33204025